S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
How major US stock indexes fared Friday, 4/12/2024
5 Trends You Need to Know This Quarter
MarketBeat Week in Review – 4/8 - 4/12
Faced with possibly paying for news, Google removes links to California news sites for some users
The US and UK restrict the trade of Russian-origin metals
Argentina's populist president meets billionaire Elon Musk in Texas — and a bromance is born
It's the first drug shown to slow Alzheimer's. Why is is it off to a slow start?
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
How major US stock indexes fared Friday, 4/12/2024
5 Trends You Need to Know This Quarter
MarketBeat Week in Review – 4/8 - 4/12
Faced with possibly paying for news, Google removes links to California news sites for some users
The US and UK restrict the trade of Russian-origin metals
Argentina's populist president meets billionaire Elon Musk in Texas — and a bromance is born
It's the first drug shown to slow Alzheimer's. Why is is it off to a slow start?
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
How major US stock indexes fared Friday, 4/12/2024
5 Trends You Need to Know This Quarter
MarketBeat Week in Review – 4/8 - 4/12
Faced with possibly paying for news, Google removes links to California news sites for some users
The US and UK restrict the trade of Russian-origin metals
Argentina's populist president meets billionaire Elon Musk in Texas — and a bromance is born
It's the first drug shown to slow Alzheimer's. Why is is it off to a slow start?
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
How major US stock indexes fared Friday, 4/12/2024
5 Trends You Need to Know This Quarter
MarketBeat Week in Review – 4/8 - 4/12
Faced with possibly paying for news, Google removes links to California news sites for some users
The US and UK restrict the trade of Russian-origin metals
Argentina's populist president meets billionaire Elon Musk in Texas — and a bromance is born
It's the first drug shown to slow Alzheimer's. Why is is it off to a slow start?
LON:APH

Alliance Pharma (APH) Share Price, News & Analysis

GBX 37.65
-0.25 (-0.66%)
(As of 04/12/2024 ET)
Today's Range
37.36
38.81
50-Day Range
36.35
44.80
52-Week Range
33.70
73.04
Volume
425,681 shs
Average Volume
778,955 shs
Market Capitalization
£203.46 million
P/E Ratio
N/A
Dividend Yield
5.31%
Price Target
GBX 80.75

Alliance Pharma MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.75 Rating Score
Upside/​Downside
114.5% Upside
GBX 80.75 Price Target
Short Interest
N/A
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.19 out of 5 stars

APH stock logo

About Alliance Pharma Stock (LON:APH)

Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. The company also offers medicines, medical devices, food supplements, and cosmetics. It provides its products under the Aloclair, Anbesol, Asthon and Parsons, Forceval, Hydromol, Kelo-cote, Macushield, Vamousse, Nizoral, and Amberen brand names. Alliance Pharma plc was incorporated in 1996 and is headquartered in Chippenham, the United Kingdom.

APH Stock Price History

APH Stock News Headlines

SHOCKING Altcoin Moves…
Bitcoin's recent price boom has sent select altcoins into an absolute FRENZY! Which is why we've gathered 27 crypto experts to share their top picks and predictions as we rapidly approach the Bitcoin halving event this month…
Alliance Pharma PLC APH
Alliance Pharma (ALAPH)
SHOCKING Altcoin Moves…
Bitcoin's recent price boom has sent select altcoins into an absolute FRENZY! Which is why we've gathered 27 crypto experts to share their top picks and predictions as we rapidly approach the Bitcoin halving event this month…
Alliance Pharma
The Alliance Pharma share price – where next?
7 top AIM market shares to buy now
See More Headlines
Receive APH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Alliance Pharma and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
285
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
GBX 80.75
High Stock Price Target
GBX 105
Low Stock Price Target
GBX 53
Potential Upside/Downside
+114.5%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
4 Analysts

Profitability

Net Income
£-7,060,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£170.05 million
Cash Flow
GBX 4.79 per share
Book Value
GBX 51 per share

Miscellaneous

Free Float
N/A
Market Cap
£203.46 million
Optionable
Not Optionable
Beta
0.60
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives

  • Mr. Andrew Timothy Franklin (Age 58)
    Interim CEO, CFO & Executive Director
    Comp: $271.52k
  • Mr. Peter Jonathan Butterfield (Age 48)
    CEO & Executive Director (Leave of Absence)
    Comp: $399.83k
  • Mr. Jeyan Heper (Hons) (Age 50)
    BA, COO & Director
  • Mr. Stephen Kidner
    Chief Scientific Affairs Officer
  • Ms. Cora Maeve McCallum C.F.A.
    Head of Investor Relations & Corporate Communications
  • Mr. Christodoulos Theoclis Chrysanthou
    Group General Counsel & Company Secretary
  • Mr. Alex Duggan
    Chief Commercial & Corporate Development Officer
  • Julie Skinner
    Chief People Officer
  • Chris Delafield
    Global Marketing Head of Kelo-Cote
  • Rhodri Smith
    Head of Sourcing

APH Stock Analysis - Frequently Asked Questions

Should I buy or sell Alliance Pharma stock right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Alliance Pharma in the last twelve months. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" APH shares.
View APH analyst ratings
or view top-rated stocks.

What is Alliance Pharma's stock price target for 2024?

4 equities research analysts have issued twelve-month price targets for Alliance Pharma's shares. Their APH share price targets range from GBX 53 to GBX 105. On average, they expect the company's share price to reach GBX 80.75 in the next year. This suggests a possible upside of 114.5% from the stock's current price.
View analysts price targets for APH
or view top-rated stocks among Wall Street analysts.

How have APH shares performed in 2024?

Alliance Pharma's stock was trading at GBX 40.50 on January 1st, 2024. Since then, APH shares have decreased by 7.0% and is now trading at GBX 37.65.
View the best growth stocks for 2024 here
.

Is Alliance Pharma a good dividend stock?

Alliance Pharma (LON:APH) pays an annual dividend of GBX 2 per share and currently has a dividend yield of 3.75%.
Read our dividend analysis for APH.

What other stocks do shareholders of Alliance Pharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Alliance Pharma investors own include RPC Group (RPC), American Airlines Group (AAL), BlackBerry (BB), Editas Medicine (EDIT), 1-800-FLOWERS.COM (FLWS), Air Canada (AC), Ally Financial (ALLY), Aviva (AV), BAE Systems (BA) and Berry Global Group (BERY).

How do I buy shares of Alliance Pharma?

Shares of APH stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:APH) was last updated on 4/13/2024 by MarketBeat.com Staff

From Our Partners